Barcelona, Spain

Silvia Gual Roig

USPTO Granted Patents = 8 

 

 

Average Co-Inventor Count = 4.3

ph-index = 3

Forward Citations = 31(Granted Patents)


Location History:

  • Cabrera de Mar, ES (2011 - 2013)
  • Barcelona, ES (2016 - 2019)

Company Filing History:


Years Active: 2011-2019

Loading Chart...
Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: Innovations by Silvia Gual Roig

Introduction

Silvia Gual Roig is a prominent inventor based in Barcelona, Spain. She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds with dual activities. With a total of eight patents to her name, her work has had a considerable impact on respiratory therapies.

Latest Patents

Among her latest patents are "Cyclohexylamine derivatives having β2 adrenergic agonist and M3 muscarinic antagonist activities" and "Bicyclic derivatives having β2 adrenergic agonist and M3 muscarinic antagonist activities." These inventions relate to novel compounds that exhibit dual activity, which can be utilized in pharmaceutical compositions for respiratory treatments. The processes for their preparation and application in therapies highlight her innovative approach to addressing respiratory issues.

Career Highlights

Silvia has worked with notable companies such as Almirall, S.A. and Laboratories Almirall, S.A. Her experience in these organizations has allowed her to refine her skills and contribute to groundbreaking research in her field.

Collaborations

Some of her coworkers include Carlos Puig Duran and Jose Aiguade Bosch. Their collaboration has likely fostered an environment of innovation and creativity, leading to the development of impactful pharmaceutical solutions.

Conclusion

Silvia Gual Roig's contributions to the field of pharmaceuticals through her patents and collaborations demonstrate her commitment to advancing respiratory therapies. Her work continues to inspire future innovations in the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…